Author Correction: CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancer.
Where this comes from
- Record sourced from PubMed, PMID 31996688.
- Also identified by DOI 10.1038/s41467-020-14429-3 and PMC identifier 6989459.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
An amendment to this paper has been published and can be accessed via a link at the top of the paper.